Further, glucagon could block vascular endothelial growth factor (VEGF) expression through the glucagon receptor and inhibit VEGF/VEGF receptor2 (VEGFR2) signaling, resulting in impaired tumor angiogenesis. This evidence concerns the gene KDR and neoplasm.